Electrocardiogram with Artificial Intelligence Assessment as a Predictor of Cardiac Events and Overall Survival in Patients Receiving Radiotherapy for Esophageal Cancer
Roman O. Kowalchuk(Mayo Clinic in Arizona), Christopher L. Hallemeier(Mayo Clinic in Arizona), Peter A. Noseworthy(Mayo Clinic in Arizona), David M. Routman(Mayo Clinic in Arizona), Zachi I. Attia(Mayo Clinic), Michael G. Haddock(Mayo Clinic in Arizona), William G. Breen(Mayo Clinic in Arizona), Krishan R. Jethwa(Mayo Clinic), Kenneth W. Merrell(Mayo Clinic), Joerg Herrmann(Mayo Clinic), T.M. Weiskittle(Mayo Clinic in Arizona), W.S. Harmsen(Mayo Clinic), Paul A. Friedman(Mayo Clinic)
International Journal of Radiation Oncology*Biology*Physics
September 29, 2023
Cited by 1
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram
|Nature Medicine|2018|1.3k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589